Drug Type ASO |
Synonyms- |
Target |
Mechanism Nav1.1 modulators(Sodium channel protein type I alpha subunit modulators) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization Camp4 Therapeutics Corp.Startup |
Active Organization- |
Inactive Organization Camp4 Therapeutics Corp.Startup |
Drug Highest PhasePendingPreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Epilepsies, Myoclonic | Preclinical | US | Camp4 Therapeutics Corp.Startup | 03 Dec 2021 |